Does LEVOMILNACIPRAN Cause Gait inability? 135 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 135 reports of Gait inability have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 9.8% of all adverse event reports for LEVOMILNACIPRAN.
135
Reports of Gait inability with LEVOMILNACIPRAN
9.8%
of all LEVOMILNACIPRAN reports
134
Deaths
90
Hospitalizations
How Dangerous Is Gait inability From LEVOMILNACIPRAN?
Of the 135 reports, 134 (99.3%) resulted in death, 90 (66.7%) required hospitalization, and 91 (67.4%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 135 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOMILNACIPRAN Cause?
Off label use (376)
Drug ineffective (315)
Gastrooesophageal reflux disease (295)
Vomiting (294)
Hypoaesthesia (290)
Abdominal pain upper (285)
Paraesthesia (282)
Memory impairment (277)
Blepharospasm (276)
Taste disorder (276)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which LEVOMILNACIPRAN Alternatives Have Lower Gait inability Risk?
LEVOMILNACIPRAN vs LEVONORGESTREL
LEVOMILNACIPRAN vs LEVORPHANOL
LEVOMILNACIPRAN vs LEVOSIMENDAN
LEVOMILNACIPRAN vs LEVOSULPIRIDE
LEVOMILNACIPRAN vs LEVOTHYROXINE